INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 1 filers reported holding INTERSECT ENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $17,000 | 0.0% | 623 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $17,000 | 0.0% | 623 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $17,000 | -19.0% | 623 | -49.1% | 0.00% | -33.3% |
Q2 2021 | $21,000 | -58.0% | 1,223 | -49.0% | 0.00% | -66.7% |
Q1 2021 | $50,000 | -9.1% | 2,397 | 0.0% | 0.01% | -18.2% |
Q4 2020 | $55,000 | – | 2,397 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,332,773 | $27,828,000 | 5.75% |
First Light Asset Management, LLC | 2,036,645 | $42,525,000 | 2.82% |
Altium Capital Management LP | 141,856 | $2,962,000 | 0.82% |
PURA VIDA INVESTMENTS, LLC | 909,660 | $18,994,000 | 0.54% |
Rock Springs Capital Management LP | 1,080,200 | $22,555,000 | 0.49% |
Novo Holdings A/S | 508,922 | $10,626,000 | 0.44% |
Davide Leone & Partners Investment Co Ltd. | 109,240 | $2,281,000 | 0.28% |
PURA VIDA INVESTMENTS, LLC | 256,800 | $5,362,000 | 0.15% |
Bellevue Group AG | 617,968 | $12,903,000 | 0.14% |
Gyon Technologies Capital Management, LP | 13,318 | $278,000 | 0.12% |